ABSTRACT
Domestic and foreign literatures related to the persistence of SARS-CoV-2 and the re-positive cases infected with SARS-CoV-2 were reviewed, and the characteristics and infectivity of the re-positive cases were analyzed to provide scientific evidence for the improvement of case management and the development of measures to stop the spread of SARS-CoV-2. Existing studies have shown that re-positive rate of SARS-CoV-2 ranged from 2.4% to 19.8%, the median of interval between re-positive detection and discharge was 4-15 days. Following the second course of the disease, the anti-SARS-CoV-2 IgM, IgG and IgA positive rates of the cases were 11.11%-86.08%, 52.00%-100.00% and 61.54%-100.00% respectively, the total antibody and neutralizing antibody positive rates were 98.72% and 88.46%. The viral load of the re-positive cases was lower than that in the initial infection. At least 3 380 re-positive cases have been reported globally. SARS-CoV-2 strains were isolated from the samples of 3 re-positive cases (1 immunodeficiency case and 2 cases with abnormal pulmonary imaging). There were close contacts that were infected by an asymptomatic case taking immunosuppressive agents. In conclusion, the infectivity of re-positive cases infected with SARS-CoV-2 is generally very low. Rare re-positive cases infected with SARS-CoV-2 might cause further transmission. The management approach for the re-positive cases can be based on the assessment of the individual transmission risk according to the pathogen detection results.
Subject(s)
Humans , Antibodies, Neutralizing , Antibodies, Viral , COVID-19 , Immunoglobulin M , SARS-CoV-2ABSTRACT
Objective:To understand the missing report rate and reporting status of infectious diseases in private medical institutions and discuss the defects involved, so as to provide a scientific basis for further standardizing the management of infectious disease reporting.Methods:By virtue of onsite data collection and face-to-face interview of 16 private hospitals in Chaoyang district of Beijing from January to May 2019, which were equipped with direct network report system, qualitative and quantitative data of their current infectious disease reporting were collected. Ratio or constituent ratio indicators was used to describe sample characteristics and survey indicators, while the ratio or constituent ratio were compared via χ2 test. Results:The missing report rate of these hospitals was 11.73%. Top three infectious diseases neglected were acute hemorrhagic conjunctivitis(100.00%), genital herpes(100.00%)and viral hepatitis(96.36%). The missing report rate of inpatients was higher than that of outpatients, and that of chronic infectious diseases was higher than that of acute infectious diseases. These hospitals were found with such defects as insufficient training of infectious disease diagnosis, and poor self-inspecting regulations and poor management actions.Conclusions:The missing reports rate of infectious diseases was high among private hospitals in Chaoyang district, especially that of chronic infectious diseases. It is necessary to strengthen infectious disease diagnosis training, and further standardize the infectious disease reporting process in hospitals using the electronic information systems, so as to reduce underreporting and consolidate infectious disease prevention and control in hospitals.
ABSTRACT
Macrophage migration inhibitory factor (MIF) is involved in a variety of physiological and pathological processes. Pathological increase of MIF is sufficient to promote inflammation, aggravate metabolic dysfunction, and increase oxidative stress. MIF inhibition, through either gene knockout or pharmacological inhibitors, is clinically beneficial for treatment. Ironically, both detrimental and beneficial effects of MIF have been reported in ischemic stroke, neurodegenerative diseases, and spinal cord injury; thus, the roles of MIF appear to be bidirectional in the central nervous system. In the current review, we focus on the roles of MIF in the central nervous system, as well as its regulating mechanisms.
ABSTRACT
Acute aortic dissection (AAD) is a potentially catastrophic cardiovascular disease,with significant morbidity and mortality,and it remains a challenge to diagnose and treat.Survival rate has been shown to be directly related to prompt diagnosis and precise management,it is necessary for early diagnosis and treatment.However,diagnosis of the disease relies heavily on various imaging techniques,remaining time-consuming and difficult to obtain.Nevertheless,the application of biomarkers provides a new direction for the diagnosis of AAD.Therefore,the application of biomarkers with high specificity and sensitivity contribute to optimal treatment to reduce the mortality rate is the current research direction.This article was to summarize the domestic and abroad research advances which focused on the biomarkers and progress of aortic dissection.